{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T03:10:01Z","timestamp":1760584201465,"version":"build-2065373602"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K09251"],"award-info":[{"award-number":["24K09251"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007830","name":"Kitasato University","doi-asserted-by":"publisher","award":["Grant for Young Researchers (2019)"],"award-info":[{"award-number":["Grant for Young Researchers (2019)"]}],"id":[{"id":"10.13039\/501100007830","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00705-025-06405-3","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T11:08:22Z","timestamp":1758625702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of a neutralizing monoclonal antibody against type I feline coronavirus with post-adsorption blocking activity"],"prefix":"10.1007","volume":"170","author":[{"given":"Tomoyoshi","family":"Doki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Kanasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhisa","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Okada","family":"Daiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3468-0708","authenticated-orcid":false,"given":"Tomomi","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"key":"6405_CR1","unstructured":"Taxon Details | ICTV https:\/\/ictv.global\/taxonomy\/taxondetails?taxnode_id=202301849&taxon_name=Alphacoronavirus%20suis. Accessed 27 Feb 2025"},{"key":"6405_CR2","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1292\/JVMS.11-0577","volume":"74","author":"S Taharaguchi","year":"2012","unstructured":"Taharaguchi S, Soma T, Hara M (2012) Prevalence of feline coronavirus antibodies in Japanese domestic cats during the past decade. J Vet Med Sci 74:1355\u20131358. https:\/\/doi.org\/10.1292\/JVMS.11-0577","journal-title":"J Vet Med Sci"},{"key":"6405_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/J.PREVETMED.2015.01.017","volume":"119","author":"BK Tekelioglu","year":"2015","unstructured":"Tekelioglu BK, Berriatua E, Turan N et al (2015) A retrospective clinical and epidemiological study on feline coronavirus (FCoV) in cats in Istanbul, Turkey. Prev Vet Med 119:41\u201347. https:\/\/doi.org\/10.1016\/J.PREVETMED.2015.01.017","journal-title":"Prev Vet Med"},{"key":"6405_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.tvjl.2014.04.017","volume":"201","author":"NC Pedersen","year":"2014","unstructured":"Pedersen NC (2014) An update on feline infectious peritonitis: Virology and immunopathogenesis. Vet J 201:123\u2013132. https:\/\/doi.org\/10.1016\/j.tvjl.2014.04.017","journal-title":"Vet J"},{"key":"6405_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.tvjl.2014.04.016","volume":"201","author":"NC Pedersen","year":"2014","unstructured":"Pedersen NC (2014) An update on feline infectious peritonitis: Diagnostics and therapeutics. Vet J 201:133\u2013141. https:\/\/doi.org\/10.1016\/j.tvjl.2014.04.016","journal-title":"Vet J"},{"key":"6405_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/1098612X19825701","volume":"21","author":"NC Pedersen","year":"2019","unstructured":"Pedersen NC, Perron M, Bannasch M et al (2019) Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis. J Feline Med Surg 21:271\u2013281. https:\/\/doi.org\/10.1177\/1098612X19825701","journal-title":"J Feline Med Surg"},{"key":"6405_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.vetmic.2018.04.026","volume":"219","author":"BG Murphy","year":"2018","unstructured":"Murphy BG, Perron M, Murakami E et al (2018) The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies. Vet Microbiol 219:226\u2013233. https:\/\/doi.org\/10.1016\/j.vetmic.2018.04.026","journal-title":"Vet Microbiol"},{"key":"6405_CR8","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1111\/jvim.15780","volume":"34","author":"PJ Dickinson","year":"2020","unstructured":"Dickinson PJ, Bannasch M, Thomasy SM et al (2020) Antiviral treatment using the adenosine nucleoside analogue GS-441524 in cats with clinically diagnosed neurological feline infectious peritonitis. J Vet Intern Med 34:1587\u20131593. https:\/\/doi.org\/10.1111\/jvim.15780","journal-title":"J Vet Intern Med"},{"key":"6405_CR9","doi-asserted-by":"publisher","first-page":"11754","DOI":"10.1128\/JVI.01348-12","volume":"86","author":"Y Kim","year":"2012","unstructured":"Kim Y, Lovell S, Tiew K-C et al (2012) Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses. J Virol 86:11754\u201311762. https:\/\/doi.org\/10.1128\/JVI.01348-12","journal-title":"J Virol"},{"key":"6405_CR10","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1177\/1098612X17729626","volume":"20","author":"NC Pedersen","year":"2018","unstructured":"Pedersen NC, Kim Y, Liu H et al (2018) Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis. J Feline Med Surg 20:378\u2013392. https:\/\/doi.org\/10.1177\/1098612X17729626","journal-title":"J Feline Med Surg"},{"key":"6405_CR11","doi-asserted-by":"crossref","unstructured":"Tekes G, Thiel HJ (2016) Feline coronaviruses: pathogenesis of feline infectious peritonitis. In: Advances in virus research. Academic Press, 193\u2013218","DOI":"10.1016\/bs.aivir.2016.08.002"},{"key":"6405_CR12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.virol.2017.12.027","volume":"517","author":"JA Jaimes","year":"2018","unstructured":"Jaimes JA, Whittaker GR (2018) Feline coronavirus: Insights into viral pathogenesis based on the spike protein structure and function. Virology 517:108\u2013121. https:\/\/doi.org\/10.1016\/j.virol.2017.12.027","journal-title":"Virology"},{"key":"6405_CR13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/J.VETMIC.2007.04.031","volume":"124","author":"N Shiba","year":"2007","unstructured":"Shiba N, Maeda K, Kato H et al (2007) Differentiation of feline coronavirus type I and II infections by virus neutralization test. Vet Microbiol 124:348\u2013352. https:\/\/doi.org\/10.1016\/J.VETMIC.2007.04.031","journal-title":"Vet Microbiol"},{"key":"6405_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/bf01310494","volume":"117","author":"T Hohdatsu","year":"1991","unstructured":"Hohdatsu T, Okada S, Koyama H (1991) Characterization of monoclonal antibodies against feline infectious peritonitis virus type II and antigenic relationship between feline, porcine, and canine coronaviruses. Arch Virol 117:85\u201395. https:\/\/doi.org\/10.1007\/bf01310494","journal-title":"Arch Virol"},{"key":"6405_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1348-0421.1996.tb01089.x","volume":"40","author":"K Motokawa","year":"1996","unstructured":"Motokawa K, Hohdatsu T, Hashimoto H, Koyama H (1996) Comparison of the amino acid sequence and phylogenetic analysis of the peplomer, integral membrane and nucleocapsid proteins of feline, canine and porcine coronaviruses. Microbiol Immunol 40:425\u2013433","journal-title":"Microbiol Immunol"},{"key":"6405_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1292\/jvms.54.557","volume":"54","author":"T Hohdatsu","year":"1992","unstructured":"Hohdatsu T, Okada S, Ishizuka Y et al (1992) The Prevalence of Types I and II Feline Coronavirus Infections in Cats. J Vet Med Sci 54:557\u2013562. https:\/\/doi.org\/10.1292\/jvms.54.557","journal-title":"J Vet Med Sci"},{"key":"6405_CR17","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1099\/vir.0.19129-0","volume":"84","author":"DD Addie","year":"2003","unstructured":"Addie DD, Schaap IAT, Nicolson L, Jarrett O (2003) Persistence and transmission of natural type I feline coronavirus infection. J Gen Virol 84:2735\u20132744. https:\/\/doi.org\/10.1099\/vir.0.19129-0","journal-title":"J Gen Virol"},{"key":"6405_CR18","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1128\/CDLI.12.10.1209-1215.2005","volume":"12","author":"M Kummrow","year":"2005","unstructured":"Kummrow M, Meli ML, Haessig M et al (2005) Feline coronavirus serotypes 1 and 2: seroprevalence and association with disease in Switzerland. Clin Diagn Lab Immunol 12:1209\u20131215. https:\/\/doi.org\/10.1128\/CDLI.12.10.1209-1215.2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"6405_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.rvsc.2018.09.002","volume":"120","author":"T Doki","year":"2018","unstructured":"Doki T, Yabe M, Takano T, Hohdatsu T (2018) Differential induction of type I interferon by type I and type II feline coronaviruses in vitro. Res Vet Sci 120:57\u201362. https:\/\/doi.org\/10.1016\/j.rvsc.2018.09.002","journal-title":"Res Vet Sci"},{"key":"6405_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.VIROL.2018.08.022","volume":"525","author":"A O\u2019Brien","year":"2018","unstructured":"O\u2019Brien A, Mettelman RC, Volk A et al (2018) Characterizing replication kinetics and plaque production of type I feline infectious peritonitis virus in three feline cell lines. Virology 525:1\u20139. https:\/\/doi.org\/10.1016\/J.VIROL.2018.08.022","journal-title":"Virology"},{"key":"6405_CR21","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41577-021-00542-x","volume":"21","author":"PC Taylor","year":"2021","unstructured":"Taylor PC, Adams AC, Hufford MM et al (2021) Neutralizing monoclonal antibodies for treatment of COVID-19. Nat Rev Immunol 21:382\u2013393. https:\/\/doi.org\/10.1038\/s41577-021-00542-x","journal-title":"Nat Rev Immunol"},{"key":"6405_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41573-022-00495-3","volume":"2022","author":"G Pantaleo","year":"2022","unstructured":"Pantaleo G, Correia B, Fenwick C et al (2022) Antibodies to combat viral infections: development strategies and progress. Nat Rev Drug Discovery 2022:1\u201321. https:\/\/doi.org\/10.1038\/s41573-022-00495-3","journal-title":"Nat Rev Drug Discovery"},{"key":"6405_CR23","doi-asserted-by":"publisher","first-page":"11090","DOI":"10.1128\/JVI.00768-11","volume":"85","author":"D Zhou","year":"2011","unstructured":"Zhou D, Zhang Y, Li Q et al (2011) Matrix protein-specific IgA antibody inhibits measles virus replication by intracellular neutralization. J Virol 85:11090\u201311097. https:\/\/doi.org\/10.1128\/JVI.00768-11","journal-title":"J Virol"},{"key":"6405_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/J.VIROL.2014.05.038","volume":"464\u2013465","author":"P Masrinoul","year":"2014","unstructured":"Masrinoul P, Puiprom O, Tanaka A et al (2014) Monoclonal antibody targeting chikungunya virus envelope 1 protein inhibits virus release. Virology 464\u2013465:111\u2013117. https:\/\/doi.org\/10.1016\/J.VIROL.2014.05.038","journal-title":"Virology"},{"key":"6405_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/S40265-020-01452-3","volume":"81","author":"A Markham","year":"2021","unstructured":"Markham A (2021) REGN-EB3: First Approval. Drugs 81:175\u2013178. https:\/\/doi.org\/10.1007\/S40265-020-01452-3","journal-title":"Drugs"},{"key":"6405_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2165\/00003495-199958020-00009","volume":"58","author":"LJ Scott","year":"1999","unstructured":"Scott LJ, Lamb HM (1999) Palivizumab Drugs 58:305\u2013311. https:\/\/doi.org\/10.2165\/00003495-199958020-00009","journal-title":"Palivizumab Drugs"},{"key":"6405_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.12935\/JVMA1951.55.293","volume":"55","author":"M UMEHASHI","year":"2002","unstructured":"Umehashi M, Imamura T, Akiyama S, Tokiyoshi S (2002) Development and Safety of a Mouse-Cat Chimeric Antibody against the Feline Calicivirus. J Japan Veterinary Med Association 55:293\u2013297. https:\/\/doi.org\/10.12935\/JVMA1951.55.293","journal-title":"J Japan Veterinary Med Association"},{"key":"6405_CR28","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1007\/S40265-021-01620-Z","volume":"81","author":"ED Deeks","year":"2021","unstructured":"Deeks ED (2021) Casirivimab\/Imdevimab: First Approval. Drugs 81:2047\u20132055. https:\/\/doi.org\/10.1007\/S40265-021-01620-Z","journal-title":"Drugs"},{"key":"6405_CR29","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1007\/S40265-021-01626-7","volume":"81","author":"YY Syed","year":"2021","unstructured":"Syed YY (2021) Regdanvimab: First Approval. Drugs 81:2133\u20132137. https:\/\/doi.org\/10.1007\/S40265-021-01626-7","journal-title":"Drugs"},{"key":"6405_CR30","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1128\/JVI.64.3.1407-1409.1990","volume":"64","author":"H Vennema","year":"1990","unstructured":"Vennema H, de Groot RJ, Harbour DA et al (1990) Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization. J Virol 64:1407\u20131409. https:\/\/doi.org\/10.1128\/JVI.64.3.1407-1409.1990","journal-title":"J Virol"},{"key":"6405_CR31","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1292\/jvms.18-0702","volume":"81","author":"T Takano","year":"2019","unstructured":"Takano T, Yamada S, Doki T et al (2019) Pathogenesis of oral type I feline infectious peritonitis virus (FIPV) infection: Antibodydependent enhancement infection of cats with type I FIPV via the oral route. J Vet Med Sci 81:911\u2013915","journal-title":"J Vet Med Sci"},{"key":"6405_CR32","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1292\/JVMS.70.1315","volume":"70","author":"T Takano","year":"2008","unstructured":"Takano T, Kawakami C, Yamada S et al (2008) Antibody-Dependent Enhancement Occurs Upon Re-Infection with the Identical Serotype Virus in Feline Infectious Peritonitis Virus Infection. J Vet Med Sci 70:1315\u20131321. https:\/\/doi.org\/10.1292\/JVMS.70.1315","journal-title":"J Vet Med Sci"},{"key":"6405_CR33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/J.VIRUSRES.2010.12.020","volume":"156","author":"T Takano","year":"2011","unstructured":"Takano T, Tomiyama Y, Katoh Y et al (2011) Mutation of neutralizing\/antibody-dependent enhancing epitope on spike protein and 7b gene of feline infectious peritonitis virus: Influences of viral replication in monocytes\/macrophages and virulence in cats. Virus Res 156:72\u201380. https:\/\/doi.org\/10.1016\/J.VIRUSRES.2010.12.020","journal-title":"Virus Res"},{"key":"6405_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0378-1135(91)90096-X","volume":"28","author":"T Hohdatsu","year":"1991","unstructured":"Hohdatsu T, Sasamoto T, Okada S, Koyama H (1991) Antigenic analysis of feline coronaviruses with monoclonal antibodies (MAbs): Preparation of MAbs which discriminate between FIPV strain 79-1146 and FECV strain 79-1683. Vet Microbiol 28:13\u201324. https:\/\/doi.org\/10.1016\/0378-1135(91)90096-X","journal-title":"Vet Microbiol"},{"key":"6405_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-1-4939-2438-7_3\/FIGURES\/2","volume":"1282","author":"T Takano","year":"2015","unstructured":"Takano T, Hohdatsu T (2015) Serological diagnosis of feline coronavirus infection by immunochromatographic test. Coronaviruses: Methods Protocols 1282:33\u201339. https:\/\/doi.org\/10.1007\/978-1-4939-2438-7_3\/FIGURES\/2","journal-title":"Coronaviruses: Methods Protocols"},{"key":"6405_CR36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/256495a0","volume":"256","author":"G K\u00f6hler","year":"1975","unstructured":"K\u00f6hler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495\u2013497. https:\/\/doi.org\/10.1038\/256495a0","journal-title":"Nature"},{"key":"6405_CR37","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.rvsc.2013.09.005","volume":"95","author":"T Doki","year":"2013","unstructured":"Doki T, Takano T, Nishiyama Y et al (2013) Generation, characterization and therapeutic potential of anti-feline TNF-alpha MAbs for feline infectious peritonitis. Res Vet Sci 95:1248\u20131254. https:\/\/doi.org\/10.1016\/j.rvsc.2013.09.005","journal-title":"Res Vet Sci"},{"key":"6405_CR38","doi-asserted-by":"crossref","unstructured":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation | Science. https:\/\/science.sciencemag.org\/content\/367\/6483\/1260. Accessed 15 Jul 2020","DOI":"10.1126\/science.abb2507"},{"key":"6405_CR39","doi-asserted-by":"publisher","first-page":"E7348","DOI":"10.1073\/PNAS.1707304114","volume":"114","author":"J Pallesen","year":"2017","unstructured":"Pallesen J, Wang N, Corbett KS et al (2017) Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc Natl Acad Sci U S A 114:E7348\u2013E7357. https:\/\/doi.org\/10.1073\/PNAS.1707304114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6405_CR40","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00705-020-04605-7","volume":"165","author":"T Doki","year":"2020","unstructured":"Doki T, Toda M, Hasegawa N et al (2020) Therapeutic effect of an anti-human-TNF-alpha antibody and itraconazole on feline infectious peritonitis. Arch Virol 165:1197\u20131206","journal-title":"Arch Virol"},{"key":"6405_CR41","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/jmicro\/dfr031","volume":"60","author":"A Alazawy","year":"2011","unstructured":"Alazawy A, Arshad SS, Bejo MH et al (2011) Ultrastructure of Felis catus whole fetus (Fcwf-4) cell culture following infection with feline coronavirus. J Electron Microsc (Tokyo) 60:275\u2013282. https:\/\/doi.org\/10.1093\/jmicro\/dfr031","journal-title":"J Electron Microsc (Tokyo)"},{"key":"6405_CR42","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/J.IMMUNI.2021.08.016","volume":"54","author":"LA VanBlargan","year":"2021","unstructured":"VanBlargan LA, Adams LJ, Liu Z et al (2021) A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope. Immunity 54:2399\u20132416e6. https:\/\/doi.org\/10.1016\/J.IMMUNI.2021.08.016","journal-title":"Immunity"},{"key":"6405_CR43","doi-asserted-by":"publisher","unstructured":"Li C-J, Chao T-L, Chang T-Y et al (2022) Neutralizing monoclonal antibodies inhibit SARS-CoV-2 infection through blocking membrane fusion. Microbiol Spectr 10. https:\/\/doi.org\/10.1128\/SPECTRUM.01814-21","DOI":"10.1128\/SPECTRUM.01814-21"},{"key":"6405_CR44","doi-asserted-by":"publisher","first-page":"6695","DOI":"10.1128\/JVI.66.11.6695-6705.1992","volume":"66","author":"WV Corapi","year":"1992","unstructured":"Corapi WV, Olsen CW, Scott FW (1992) Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus. J Virol 66:6695\u20136705. https:\/\/doi.org\/10.1128\/JVI.66.11.6695-6705.1992","journal-title":"J Virol"},{"key":"6405_CR45","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/BF01310476","volume":"120","author":"T Hohdatsu","year":"1991","unstructured":"Hohdatsu T, Nakamura M, Ishizuka Y et al (1991) A study on the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodies. Arch Virol 120:207\u2013217. https:\/\/doi.org\/10.1007\/BF01310476","journal-title":"Arch Virol"},{"key":"6405_CR46","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/BF01310791","volume":"139","author":"T Hohdatsu","year":"1994","unstructured":"Hohdatsu T, Tokunaga J, Koyama H (1994) The role of IgG subclass of mouse monoclonal antibodies in antibody-dependent enhancement of feline infectious peritonitis virus infection of feline macrophages. Arch Virol 139:273\u2013285. https:\/\/doi.org\/10.1007\/BF01310791","journal-title":"Arch Virol"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-025-06405-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-025-06405-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-025-06405-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T02:48:18Z","timestamp":1760582898000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-025-06405-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["6405"],"URL":"https:\/\/doi.org\/10.1007\/s00705-025-06405-3","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"type":"print","value":"0304-8608"},{"type":"electronic","value":"1432-8798"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of interest"}},{"value":"All applicable national and institutional guidelines for the care and use of animals were followed. The animal experimentation protocol was approved by the President of Kitasato University through the judgment of the Institutional Animal Care and Use Committee of Kitasato University (approval no. 19\u2013069).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"209"}}